Article
HDAC Inhibition Induces Patient-Specific Phenotypic Remodeling in Glioblastoma Organoids
2026-06-28
Abstract excerpt
<title>Abstract</title> <p>Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and remains highly resistant to current therapies. Patient-derived glioblastoma organoids (gPDOs) preserve key histological and molecular features of the original tumors, providing clinically relevant models for investigating tumor biology and therapeutic vulnerabilities. Given the role of histone deacetylase (HDAC)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fa5b128-c84b-51fc-924b-41c92ea5e074
- DOI
- 10.21203/rs.3.rs-10071781/v1
